Michael Morse gets cortisone shot, hopes to play Monday

Leave a comment

Nationals outfielder Michael Morse hasn’t appeared in a Grapefruit League game since being scratched from Tuesday’s lineup against the Braves because of a mild strain of his right lat muscle. But he’s hoping to get back on the right track early this week.

From MLB.com beat writer Bill Ladson comes word that Morse was given a cortisone injection on Saturday afternoon and is hoping to feel well enough to serve as the Nationals’ designated hitter in Monday’s exhibition matchup with the Cardinals.

Morse, 29, batted .303/.360/.550 with 31 home runs and 95 RBI in 575 plate appearances last season for Washington. Nats manager Davey Johnson said Sunday that he’s on pace to be ready for Opening Day.

Report: Mets have discussed a Matt Harvey trade with at least two teams

Al Bello/Getty Images
1 Comment

Kristie Ackert of the New York Daily News reports that the Mets have discussed a trade involving starter Matt Harvey with at least two teams. Apparently, the Mets were even willing to move Harvey for a reliever.

The Mets tendered Harvey a contract on December 1. He’s entering his third and final year of arbitration eligibility and will likely see a slight bump from last season’s salary of $5.125 million. As a result, there was some thought going into late November that the Mets would non-tender Harvey.

Harvey, 28, made 18 starts and one relief appearance last year and had horrendous results. He put up a 6.70 ERA with a 67/47 K/BB ratio in 92 2/3 innings. Between his performance, his impending free agency, and his injury history, the Mets aren’t likely to get much back in return for Harvey. Even expecting a reliever in return may be too lofty.

Along with bullpen help, the Mets also need help at second base, first base, and the outfield. They don’t have many resources with which to address those needs. Ackert described the Mets’ resources as “a very limited stash of prospects” and “limited payroll space.”